-
A gun found with a suspect is similar to the ones that were used at the UnitedHealthcare CEO crime scene
New York Police Commissioner Jessica Tisch said on Wednesday that police got the gun found in the possession of Luigi Mangione, the 26-year-old suspect in Brian Thompson’s killing, back from Pennsylvania. The gun matched casings found a week ago in Manhattan, Tisch added. Mangione, a graduate of the University of Pennsylvania with a bachelor’s and…
-
The Y chromosome has an effect on cancer risk
Biotech company SanaHeal has won the Spinoff Prize, an award fromNature Research and Merck for early-stage university spin-off companies. SanaHeal was founded in 2014 by Harvard University’s evolutionary biologist Shu Jing and University of Pennsylvania’s computational biologist and genomics professor Charles Ornstein. It will receive $1 million from Nature Research and Merck for its development…
-
Crispr is being used to Cure HIV
A US-led team has used genome-editing technique CRISPR-Cas9 to alter immune cells to fight cancer in a mouse model. The research, which was conducted at the University of Pennsylvania’s Burnham Institute for Medical Research, was published in Nature Communications on Monday. The mice were injected with immune cells from their own bone marrow to treat…
-
Individualized treatments are paving the way thanks to the success of the CRISPR cancer trial.
A researcher at the University of Pennsylvania has said that a CAR-T-cell therapy that harnesses an individual’s own T cells is not the same as in other diseases. Joseph Fraietta said, “Solid tumours provide barriers to T cells, which have to move through the blood to kill the cancer cells.” He added, “In three years,…
-
The Crispr Therapy is intended to attack tumors.
Researchers at US’ University of California, Los Angeles and University of Pennsylvania have developed T-cell cancer therapies based on the creation and response of a patient’s immune system to an invader’s own T cells. They began by separating T cells from the blood of 16 patients with solid tumors, including colon, breast, or lung cancer.…
-
A Crispr therapy is designed to attack tumors.
Scientists at University of Pennsylvania in the US have discovered a way to personalise cancer therapy by editing and transporting gene expression to cancerous cells. They infused the edited cells back into volunteers who had previously been treated with several rounds of chemotherapy. The edited cells travelled to the tumors and killed them.
-
The success of the CRISPR cancer trial paves way for personalized treatments.
University of Pennsylvania researchers have developed a new approach to personalise personalised T-cell therapies for solid tumors. They isolated T cells from blood of 16 patients with solid tumors, including colon, breast, or lung cancer. The team chose up to three receptors for each patient and added the genes for these receptors to the person’s…